PAIGE WORKMAN: Open Payments
NPI 1669910758 · OLYMPIA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,478 in 74 payments from 14 companies in 2025. Trend: 2023 $686 · 2024 $1,452 · 2025 $1,478
Food & beverage: $1,360Education: $118
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 18 | $394 |
| ABBVIE INC. | 18 | $292 |
| Organon LLC | 8 | $161 |
| Arcutis Biotherapeutics, Inc. | 6 | $105 |
| GENZYME CORPORATION | 3 | $104 |
| Novartis Pharmaceuticals Corporation | 5 | $102 |
| Galderma Laboratories, L.P. | 4 | $63 |
| Incyte Corporation | 3 | $62 |
| UCB, Inc. | 2 | $57 |
| Regeneron Healthcare Solutions, Inc. | 2 | $39 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, HADLIMA, Zoryve, COSENTYX, RINVOQ, NEMLUVIO.
Industry payments across WA — which companies pay providers there.
